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Summary.-The basal concentration of the tryptophan metabolite 3-hydroxy-
anthranilic acid (30HA), which has carcinogenic properties, was measured with an
enzymatic method of determination which allowed separate measurement of free
and conjugated 30HA. The concentration of free 30HA in untreated bladder cancer
patients was significantly (P < 0.001) higher than in a healthy control group, but
after local therapy the concentration was significantly lower than before treatment
(P < 0-01). The concentration of conjugated 30HA was nearly constant in the three
groups. It was concluded that other factors than a genetic determined abnormality
might be operating in bladder cancer patients which could lead to an abnormal
concentration of 30HA in their urine.
'rHE role of tryptophan metabolites in
the aetiology of human urinary bladder
cancer has been the subject of numerous
investigations. Twenty-two years ago a
relationship was suggested by Dunning,
Curtis and Maun (1950), who showed that
a high incidence of bladder tumours
resulted when rats were fed 2-acetyl-
aminofluorene combined with DL-trypto-
phan. Several primary aromatic amine
tryptophan metabolites, with a structure
similar to known environmental human
bladder carcinogens, are present in human
urine (Brown and Price, 1956). Direct
application to the mouse bladder of these
metabolites by the " pellet technique "
confirmed the carcinogenic activity of
several of them (Bryan, 1971). Recently,
Radomski, Glass and Deichmann (1971)
have given evidence supporting the role
of tryptophan in bladder carcinogenesis
by feeding 7 times the normal daily intake
of DL-tryptophan to beagle dogs for
periods of 3 5 months to 7 years. Marked
local hyperplasia of the transitional blad-
der epithelium was observed in all cases.
Several clinical studies of the meta-
bolism of tryptophan have been carried
out in patients with bladder cancer
(Brown et al., 1960; Price and Brown,
1962; Benassi, Perissinotto and Allegri,
1963; Kochen and Hochberg, 1970). In
these investigations one or more meta-
bolites were determined in samples of
24-hour urine. In most of the studies,
loading with an oral dose of L-tryptophan
was necessary because the analytical
methods are working at lower limits of
detection and sensitivity when used on
basal urines. Because of the differences
in method, it is difficult to compare the
results obtained in the different labora-
tories. An abnormal metabolism was
often observed in patients with spontane-
ous bladder cancer, but in other patho-
logical conditions an abnormal excretion
pattern was also found (Rose, 1-972).
Moreover, the excretion of metabolites is
related to tryptophan intake, hormonal
regulation of the pathway, intake levels
of pyridoxine and metabolic individualitv
(Albanese et al., 1972). In a pilot studyFREE AND CONJUGATED 3-HYDROXYANTHRANILIC ACID
(unpublished), we determined the meta-
bolites 3-hydroxyanthranilic acid, 3-hyd-
roxykynurenine and kynurenine using the
methods of Brown and Price (1956) as
modified by Heeley (1965). A signifi-
cantly lower amount of 3-hydroxyanthra-
nilic acid was found in the (basal) 24-hour
urine collections in a series (28) ofpatients
after radiotherapy treatment for a bladder
tumour, when compared with the amounts
excreted in this series before treatment.
The difference was not significant when a
loading of 2 g of L-tryptophan was given
to the patients.
Because the method has the disad-
vantage of inspecificity, a sensitive and
specific enzymatic method for the deter-
mination of 30HA has been evaluated.
With this method both unconjugated and
conjugated 30HA have been estimated.
The differences between groups of un-
treated bladder tumour patients, treated
patients without detectable bladder malig-
nancy and healthy controls were deter-
mined.
MATERIALS AND METHODS
The enzyme 30HA-oxidase (EC 1.13.1.6)
converts 30HA to I-amino-4-formyl-buta-
diene, 1-2 dicarboxylate. This substance has
a high molar extinction coefficient at 360 nm
and the amount formed is directly propor-
tional to the amount of30HA.
The enzyme was obtained by the method
of Wiss, Simmer and Peters (1956) with
some modifications. Fresh or frozen calf
liver (obtained from the localslaughterhouse)
was homogenized with 5 parts of water in a
household mixer (3 min). After centrifuga-
tion (3600 g; 30 min, 4°C) an acetone frac-
tionation was performed at minus 10°C. The
45-55 vol % fraction was collected by centri-
fugation (3600 g; 10 min, - 10°C) and the
precipitate was lyophilized, and stored in
vacuo at - 80°C. Before use, part of this
lyophilized precipitate was dissolved in
30 mmol/l sodium acetate buffer (pH 7.4),
and ferrous sulphate (1 mmol/l) was added.
This solution was heated in a stainless
steel beaker for exactly 5 min at 55°C. The
heating procedure was terminated by cooling
with ice. After centrifugation (3600 g;
10 min, 4°C) and discarding the precipitate,
the enzyme solution was distributed over 1 ml
glass ampoules, which were sealed and stored
at - 80TC for maximally 3 months before
use.
The procedure results in a preparation
which has 1700 times higher 30HA-oxidase
activity per mg protein than the super-
natant of the homogenate. The preparation
was iinactive with 3-hydroxykynurenine,
kynurenine and anthranilic acid.
For the determination of 30HA an inter-
nal standard method was used as proposed by
Schievelbein and Buchfink (1967). 1-5 ml of
fresh urine and 8-5 ml of a 67 mmol/l oxygen
saturated tris (hydroxymethyl)-amino meth-
ane buffer (pH 7-1) were transferred to a
40 mm lightpath glass cuvette. 0 5 ml of
enzyme was mixed with 3.5 ml of the same
-buffer and transferred into two 2 ml syringes.
'Both syringes were attached to an adaptor
on the spectrophotometer (Optica CF4R),
and from the adaptor 10 cm pieces of 1 6 mm
Teflon tubing led to the bottom of the glass
cuvette.
The reaction was started by injecting the
contents of both syringes simultaneously
(to). The increasing absorbance (E) at
360 nm was registrated on a recorder. Due
to mixing turbulences it was impossible to
estimate E during the first seconds after
injection. Mixing of the enzyme with 30HA
gives a small unreproducible change in the
summed E's of the components. Because it
is also impossible to estimate the zero time
value from a blank, a mathematical method
was used to estimate the total rise in E due
to the formationofthereactionproduct. The
method is illustrated in Fig. 1. On the left
side of the figure the directly recorded pro-
gress ofthereaction is shown (arrow indicates
the start to). Within 1 min a plateau in E
is reached (E = A). Whenthevalues obtain-
ed for E from t = 7s until t = 25s are
subtracted from A, and the resulting values
D are plotted on a logarithmic scale (right
side of Fig. 1) a straight line is obtained.
The maximum increase Do can be calculated
by extrapolation of the line to to by a least
square method. The concentration 30HA
was calculated as Do/E.1 (E = molar extinc-
tion coefficient of the product = 47 000;
1 = lightpath) and correcting this value for
urine dilution.
To obtain more accurate readings, the
absorption was read automatically (digital
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Fi. 1.-The recorded reaction course and the method of calculating the maximal inicrease in
absorbance (as explained under Materials and Methods).
voltage meter coupled to a (ligital transfer
unit) and punched in tape (Teletype). The
tapes were read by a Hewlett Packard 9100 B
calculator with tape reader, and the amount
of30HA was calculated by the programmed
calculator. The determinations were per-
formed in duplicate, and repeated in duplicate
with an internal standard 30HA (5 nmol) to
calculate the recovery. The amount of
total 30HA was determined after hydrolyzing
the urine with HCl (0 4 mol/l HCl, during
24 hours at 4°C). As estimated, in some
experiments the amount of total 30HA was
maximal after 6-24 hours, but when the
hydrolysis was extended to 48 hours a loss
of 30HA in some urines occurred. Forthe
determination the pH of the hydrolysed
urine was adjusted to 7-2.
To correct for losses during hydrolysis, an
internal standard of 30HA (80 nmol) was
added to 10 ml of the urine. The determina-
tion was carried out as described above.
When the amount 30HA found in the first
determination is subtracted from the amount
determined in the second, the amount conju-
gated 30HA is found. The concentration of
free, conjugated and total 30HA is expressed
in " Fmol 30HA/l " (mol. wt. = 153).
Accuracy of the determinations.-Because
the accuracy of the determinations was
estimated on 0 010 units in optical density
(as well as in the determninations of the added
standards), an accuracy of 0.6 Mumol/l in the
determinations of free 30HA, and 09 jumo1/1
in the determination of total 30HA could be
expected at recovery values of 80%.
Patients.-Because we wanted to make the
determinations in the urine immediately
after voiding, only urines of patients and
healthy persons present in the clinic were
analysed. To avoid any influence on the
results by sex differences, only male subjects
were taken into this study; they were left
on their normal diet. The determinations
were carried out between 9'00 and 15-00.
In a preliminary study in 10 patients a
straight line could be obtained when the
cumulative excretion of 30HA was plotted
over this time, and we concluded that no
important differences in the excretion occur-
red during the time period. The cumulative
volume of the urines was also fairly constant.
Because only the mean concentrations of
30HA for a group are compared in this study,
individual fluctuations in 30HA concentra-
tions are cancelled out.
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TABLE I.-Distribution ofthe Concentration ofFree, Total and Conjugated 30HA
over the C, B and TB Groups
/Lmol/l <0 3 0-3-0 9 1-0-1-8 1-9-2-9 3-0-4-2 4-3-6-9 7-0-10-0 10-1-14-7
Free 30HA C 12 5 5 8 5 4
B 1 0 5 9 10 13 2 1
TB 3 3 8 8 4 4 1
Median values: C = 1 * 2 ymol/l; B = 3 - 4 ,umol/l; TB =1 * 7 ,umol/l.
,umol/l <0 7 0-7-1-3 1-42-8 2-9-5-1 5-2-8-8 8-9-14-7 14-8-24-8
Total 30HA C 8 2 6 8 8 5 2
B 1 2 2 13 13 7 3
TB 3 0 5 13 8 1 1
Median values: C = 3 - 4 ,umol/l; B = 5 - 6 ,umol/l; TB = 3 - 9 ,umol/l.
limol/I <0 4 0-41-4 1-5-3-9 40-9 0 9-1-18-9 >18-9
Conjugated( C 13 6 11 5 4
30HA B 12 8 8 9 3 1
TB 5 9 13 2 2
Aledian values: C = 1 * 5 ,umol/l; B = 1 * 4 ,umol/l; TB = 1 5 ,umol/l.
Category C'" : controls-.This group was
built up of hospital personnel and patients
visiting the clinic for the follow-up of cured
skin tumours. Because no differences could
be found in the concentration of the meta-
bolite between these groups, they were taken
together in the control group.
Category B ": patients with a bladder
tnmour confirmied by cystoscopy but uwithout
radiation therapy.-In general these patients
had their urine tested during the first or
second day after hospitalization.
Category ' TB ": patients treated for a
bladder tumour.-All patients in this group
were free of bladder tumour, as examined
by follow-up cystoscopy, at the moment of
30HA determination. Ten patients were
analysed within 4 months after treatment,
9 after 5-8 months, 4 after 9-12 months
and 5 after 2-12 years.
Nine patients in Group B were repeated
in Group TB.
RESULTS
In Table I the results for the concen-
tration of free, total (after hydrolysis) and
conjugated (total minus free) are given
for the 3 groups.
The accuracy of the determination of
the total 30HA concentration is less than
the accuracy of the free 30HA concentra-
tion (see Methods). While the accuracy
of the determinations of free and total
30HA was +0 6 ,amol/l and +0 9 ,amol/l,
sometimes a negative difference was
found in the calculation of the concentra-
tion of conjugated 30HA. These values
are considered as smaller than 0-4 ,amol/l.
TABLE II. X2 Test for Significant Differ-
ences for the Distributions in Table I
C-B B-TB
Free 30HA P<0-001 P<0-01
Total 30HA I'<0*05 NS
Conjugated 30HA NS NS
(NS=not significantly different)
C -TB
NS
NS
NS
The data were tested for differences
between the groups with the x2 test. The
results are presented in Table II. To
compare the mean concentration of free,
total and conjugated 30HA, the concen-
tration values were transformed to log1o
(concentration + 1.0). Because the trans-
formed values are distributed normally,
the mean and 95% confidence limits
could be calculated (Fig. 2).
In Table III the groups are compared
for different parameters.
The mean recovery of the added stan-
dard amount of 30HA during the analy-
sis and during the hydrolysis was always
between 80 and 90 % in the 3 groups.
There is no reason to assume that in any
group substances are present in the urine
which inhibit the enzyme, although in
some urines the inhibition was remarkable.
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total 3 OHA
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conjugoted 3 OHA
No
and 95% confidence limits. log10 (concentration 30HA + 1),
conjugated 30HA in the groups C, B and TB.
,in groups
of free, total and
TABLE III.-Comparison ofDifferent Parameters
Age (years)
Weight (kg)
Creatinin mmol/l
Volume ofurine (ml)
Time in bladder1
(min)
C
C
B
'I
Group
mean
61-0
3 66-7
PB 64- 0
z 76-7
3 72-3
'B 74-8
J 13*5
3 10-4
'B 10-0
150
3 136
'B 147
199
3 160
'B 135
95% confidence
limits
58-8--63*12
63- 7-69- 82
60 4-67-6
73-80
68-76
71-78
11*5-15-43
8- 7-12- 13
7- 6-12-43
120-180
112-160
112-182
150-2454
130-190
110-1604
Range
45-74
43-85
42-80
53-106
42-100
54-91
1*4-27-9
4-5-29-1
1 8-27-5
36-650
30-325
15-470
60-745
30-465
25-315
1 Time during which the analysed urine portion accumulated into the bladder. 2 0-95 :C-B.
3P6 0-95 :C-B;C-TB.
4P<0 95:C-TB. -
DISCUSSION:
The role of tryptophan metabolites in
the aetiology ofbladder cancer is not clear.
Tryptophan and its metabolites are sus-
pected of being carcinogenic or cocarcino-
genic agents, and in many studies abnor-
malities in the excretion pattern of
tryptophan metabolites in patients with
bl-adder cancer have been detected. This
suggests that the abnormality could be a
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cause for spontaneous bladder tumours.
But the induction time for bladder
tumours is in general very long, and an
abnormal metabolism at the time of the
detection of the tumour cannot give
certainty that the abnormality already
existed at the time of induction. A
genetically determined abnormality should
still exist when the patient is cured of the
tumour. In these studies the concentra-
tion of the metabolite 3-hydroxyanthra-
nilic acid is compared in bladder tumour
patients, after confirmation of the disease
before treatment, with the excretion in a
group of patients during the follow-up
period after local cure of the bladder
tumour.
It was already presumed by Boyland
and Williams (1956) that the metabolite
could be excreted in the urine as the
conjugated glucuronide, and that the
carcinogenic activity followed after enzy-
matic hydrolysis by /,-glucuronidase in
the urine.
Very recently it was confirmed by
Watanabe, Ohkubo and Tamura (19972)
and Watanabe and Minegisli (1972) that
enzymatic formation of the glucuronide
and also of the sulphuric ester of 30HA
are possible. The enzymatic hydro-
lysis of both conjugates by 8-glucuron-
idase or arylsulphatase obtained from
human urine, however, occurs slowly.
We were able to show in an earlier study
(Haye and van der Werf-Messing, 1962)
that a relationship between high /f-glucu-
ronidase levels in the urine and the occur-
rence ofbladder cancer is not very likely.
In all cases the determinations of free
30HA were carried out within one hour
of urine collection, and in this way a
shift from conjugated to free 30HA
by the action of urinary enzymes was
prevented as much as possible. From the
statistical analysis of the results, the
conclusion can be drawn that the concen-
tration of free 30HA in the tumour group
(B) is significantly higher than in the
control (C) and locally cured (TB) group.
The same conclusion can be drawn from
the results for the total amount of 30HA,
but because the accuracy ofthe determina-
tion of total 30HA is lower, resulting in a
larger deviation, the degree of significance
of the differences is lower.
Because the concentration of conju-
gated 301HA was calculated from the
difference between the total and free
30HA the accuracy of this determination
is low, but seems to be fairly constant
over the 3 groups. This suggests that
the differences between the groups are
mainly differences in the concentration of
free 30HA. It can be questioned to
what extent the factors regulating the
tryptophan metabolism play a role in the
30HA exeretion. When the pathway is
operating under certain circumstances at
a higher level, more 30HA will be formed
but more will be broken down by the
30HA oxidase. The finding of a higher
excretion level of 30HA in the bladder
tumour patients, however, suggests a
partial blocking of the enzymatic conver-
sion of 30HA.
The 30HA-oxidase catalyses a bi-sub-
strate reaction, with oxygen as the second
substrate. Because we used this enzyme
for our determination, it was remarkable
that it was necessary to saturate the
reaction mixture with oxygen to obtain
reproducible determinations.
It is difficult to explain the higher
excretion in the bladder tumour group.
Emotional and )physical stress can stimu-
late the output of glucocorticoids by the
adrenal glands, which results in a higher
input of tryptophan into the kynurenine
pathway, due to the activation of the
tryptophan oxygenase (Rose and McGin-
thy, 1970). Experimental tumours in
animals can activate the tryptophan
oxygenase as a result of the physical
stress caused by bearing a tumour (Green-
gard, 1967).
The significantly lower concentration
of free 30HA in the TB group cannot
support the hypothesis that a genetic
abnormality is due to the abnormal con-
centration of 3011A in bladder tumour
patients. The mean concentration of
30HA in the locally treated group (TB)
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tends to be somewhat higher than the
concentration in the control group (C)
but, as shown in Table III, there are also
differences between the groups with respect
to age, creatinine concentration and the
time during which the urine was collected
into the bladder. For future study it
would be of interest to examine cases of
recurrent local growth to see whether the
concentration of 30HA returns to abnor-
mal levels.
The authors are indebted to their
many colleagues for supplying clinical
material for this study and to Mrs G. E.
Mulder-Kooy, Mr H. Portengen, Mr H. A.
Peters and Mr M. S. Henkelman for their
excellent technical assistance.
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